HCH reported revenue growth in Q1 and is actively promoting investments in the consulting and commissioned development sectors.

Human Creation Holdings <7361> announced on the 10th its consolidated financial results for the first quarter of the fiscal year ending September 2026 (October-December 2025). Revenue increased by 11.6% year-over-year to 2.246 billion yen, operating income decreased by 36.9% to 134 million yen, ordinary income fell by 41.5% to 124 million yen, and net income attributable to parent company shareholders declined by 60.2% to 52 million yen. The group is actively investing in the consulting and contract development sectors to enhance its technological capabilities.

Fisco JapanFeb 25 18:43

Human Creation Holdings: Financial Results Presentation for the First Quarter of Fiscal Year 2026 (September 2026)

JPXFeb 10 14:30 · Announcements

Human Creation Holdings: First Quarter Financial Results Briefing for the Fiscal Year Ending September 2026 (Consolidated) [Japanese GAAP]

JPXFeb 10 14:30 · Announcements

Toray, Shin Nippon Pharmaceutical, Sharp, Honda (10th)

※The above calendar is only a tentative schedule and is subject to change based on company circumstances. --------------------------------------- February 10 (Tuesday) <1414> Shobond, <1446> Candyl, <167A> Ryosan Ryo-yo, <1799> Daiichi Kensetsu, <1852> Asanuma-gumi, <1866> Kitano Construction, <1960> Santech, <1963> JGC HD, <1979> Dai

Fisco JapanFeb 10 05:30

Human Creation Holdings: Financial Report - Term 9 (2024/10/01 - 2025/09/30)

EDINETDec 18, 2025 15:15 · Announcements

Human Creation Holdings To Go Ex-Dividend On September 29th, 2026 With 44 JPY Dividend Per Share

November 15th (Japan Standard Time) - $Human Creation Holdings(7361.JP)$ is trading ex-dividend on September 29th, 2026.Shareholders of record on September 30th, 2026 will receive 44 JPY dividend

Futu NewsNov 15, 2025 19:25